IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 3 holdings | $152.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$80.6K8,930,23752.9%
Inflarx NV(IFRX)COMN44821101$39.3K1,876,41325.8%
Marinus Pharmaceuticals IncCOM56854Q101$32.5K3,977,45321.3%